CME professionals' reactions to the Senate Finance Committee report on medical education run the gamut, from those who agree that pharmaceutical company funding results in biased programming to those who think the committee is wasting its time and should focus on other issues, such as Medicare fraud. Regardless of their opinions, many agree that the result will be stricter guidelines from the ACCME. “I agree wholeheartedly with the Senate Finance Committee. We all know that there are those ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the Senate CME Report Sparks Controversy, you'll also gain access to exclusive premium content.

Already registered? here.